Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Biosyngen's first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress 2024-09-18 18:18
TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging 2024-09-18 16:00
AI Plus Clinic Tamaplaza Enhances System to Provide Rapid Diagnosis and Peace of Mind with Remote Robots Starting September 2024 2024-09-18 14:00
inHearing Technology Inc. Announced the Acquisition of Intricon's Hearing Health Business 2024-09-18 10:27
Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI 2024-09-18 10:06
Breakthrough in Long COVID: An investigator-initiated trial (IIT) with Hyundai Bioscience's Xafty by UCSD 2024-09-18 09:26
Datasea's New 5G AI Multimodal Agreements Have Already Generated $9.0 Million of 5G-AI Services 2024-09-17 21:45
See-Mode Technologies Receives FDA Clearance for Thyroid Ultrasound AI Analysis and Reporting Software 2024-09-17 20:00
Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics 2024-09-17 15:47
WestGene Biopharma Presents Groundbreaking mRNA Vaccine Data at ESMO 2024 2024-09-17 00:01
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment 2024-09-16 20:00
Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment 2024-09-16 19:00
Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024 2024-09-16 18:00
Akeso's Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024 2024-09-16 15:35
Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024 2024-09-15 15:10
Dialogue with CGT Leaders! You Are Invited to Join the "2024 GenScript Biotech Global Forum•London" to Discuss the Future Together 2024-09-15 06:53
Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration 2024-09-14 19:43
Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 2024-09-14 16:06
MediLink presents YL201 (B7H3 ADC) at ESMO 2024, with over 6-months PFS in SCLC, and showing pan-tumor benefits 2024-09-14 01:00
111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation 2024-09-13 19:30
1 10 11 12 13 14 431